Australia is one of many major economies including the UK, Europe, Canada, United States, Japan and others that have unveiled trade sanctions against Russia and Belarus in recent months. Adding these new sanctions to an already complex global regulatory environment, makes it difficult to ensure trade compliance and minimise your business risk.

Please join us at the Institute of the Americas for our live in-person Distinguished Speaker event with Luis de la Calle who will be speaking about “USMCA & the Future of Mexican Economic Competitiveness”.

The coronavirus pandemic has brought about growth opportunities for the pharmaceutical industry in Chile, attracting foreign companies that have recognized the opportunity to base their operations in the country and use it as a platform for regional expansion.

Last April 5, 2022, YCP Solidiance and DFDL, a leading international law firm, presented “Keys to Successful M&A in Southeast Asia” a live webinar which addressed challenges international investors may face when striking M&A deals in the dynamic Southeast Asian market.

BLF Lawyers (BLF): GBA offers a platform for being one of the world’s largest leading innovation centres. The GBA has a combined gross domestic product of US$1.34 trillion, representing 14% of China’s national economic aggregate back in 2016, and probably more today with Guangdong’s fast pace expansion.

Join us for an online exploration to the Chengdu-Chongqing Economic Circle! It is your opportunity to learn about the economic and industrial development of the southwest of China and to build connections with potential business partners.

A summary and highlights of the recently-concluded COP26 meeting in Glasgow, Scotland. In addition, we include reflections from our fellows and team, who through their diverse perspectives considered how the results are likely to impact our hemisphere and the world.

CGA Bulletin - April 2022

The Democratic Republic of the Congo (DRC) officially joined the East African Community (EAC) on March 29, 2022, becoming its 7th Partner State.

Saudi Arabia has positioned itself as a hub for healthcare and pharmaceutical companies in the GCC region and in recent years, has been providing further regulatory coverage for companies seeking to conduct clinical trials in Saudi Arabia. The Saudi Food and Drug General Authority (“SFDA”) has published guidelines on conducting clinical trials in Saudi Arabia – these include the Guideline for Good Clinical Practice, Regulations and Requirements...